Katalyst CRO ยท 1 day ago
Computer System Validation engineer
Katalyst CRO is seeking a Computer System Validation Engineer specializing in the pharmaceutical industry. The role involves ensuring that computer-based systems comply with regulatory standards and includes responsibilities such as developing validation deliverables and collaborating with various teams to maintain system compliance.
AnalyticsBiopharmaData ManagementHuman ResourcesQuality Assurance
Responsibilities
Develop, execute, and review validation deliverables, including Validation Plans, User Requirements Specifications (URS), IQ/OQ/PQ protocols, and Summary Reports
Collaborate with Quality Assurance, IT, Engineering, and Production teams to ensure system compliance and data integrity
Support internal audits and inspections, ensuring readiness and adherence to regulatory expectations
Provide training to stakeholders on validation requirements and best practices
Maintain validation lifecycle documentation and change control records
Qualification
Required
Experience with CSV in a regulated pharmaceutical or biotech environment
Strong knowledge of GxP, FDA 21 CFR Part 11, and EU Annex 11
Proficiency in authoring and executing validation documentation
Company
Katalyst CRO
Katalyst CRO | Advancing Healthcare & Life Sciences with Expert Research & Regulatory Solutions Katalyst Healthcare & Life Sciences (Katalyst CRO) is a Global Contract Research and Knowledge Process Outsourcing Organization (CRO) dedicated to driving innovation in research, regulatory compliance, and quality excellence for pharmaceutical, biotechnology, and medical device companies worldwide.
H1B Sponsorship
Katalyst CRO has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (37)
2024 (14)
2023 (24)
2022 (52)
2021 (54)
2020 (39)
Funding
Current Stage
Growth StageRecent News
2024-04-07
Company data provided by crunchbase